Wird geladen...
Combination Therapy for Mucormycosis: Why, What, and How?
The high mortality rate of mucormycosis with currently available monotherapy, particularly in hematology patients, has stimulated interest in studying novel combinations of antifungal agents to determine whether superior outcomes might be achieved. Combination lipid polyene-echinocandin therapy is t...
Gespeichert in:
| Veröffentlicht in: | Clin Infect Dis |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2012
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4542574/ https://ncbi.nlm.nih.gov/pubmed/22247449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cir885 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|